Literature DB >> 1718424

Localization of a polynucleotide binding region in the HIV-1 reverse transcriptase: implications for primer binding.

R W Sobol1, R J Suhadolnik, A Kumar, B J Lee, D L Hatfield, S H Wilson.   

Abstract

Properties of primer recognition by purified human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) p66 homodimer have been investigated. Earlier studies had shown that RNA-directed DNA synthesis catalyzed by HIV-1 RT proceeds by an ordered mechanism in which template-primer combines with the free enzyme to form the first complex in the reaction scheme, and it was also shown that primer alone is a competitive inhibitor of template-primer. In this study, enzyme-primer binding has been further characterized utilizing pd(T)8 and pd(T)16 as model primers and UV cross-linking to covalently trap the enzyme-primer complexes. Competition experiments with several authentic primers, including tRNA(3Lys), indicate that pd(T)n binds to the kinetically significant primer binding site of RT. Salt reversal experiments suggested that the free energy of pd(T)n binding to RT has a large nonelectrostatic component. Binding of pd(T)n to p66-RT is not affected by dNTPs and does not require the presence of template. The site of UV cross-linking of pd(T)16 was localized to the NH2-terminal half of p66 by use of V8 protease hydrolysis and microsequencing. Our results indicate that a polynucleotide binding site is in close proximity to residues in the peptide comprising amino acids 195 approximately 300. This region could be either a single-stranded template or single-stranded primer binding site; however, we have documented the specificity of binding with oligonucleotides that act as primer in the in vitro DNA synthesis reaction. Therefore, this d(T)16 binding site may be part of a primer-binding groove within the HIV-1 reverse transcriptase.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1718424     DOI: 10.1021/bi00108a004

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Reduced replication of human immunodeficiency virus type 1 mutants that use reverse transcription primers other than the natural tRNA(3Lys).

Authors:  A T Das; B Klaver; B Berkhout
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

2.  Two step binding of HIV-1 reverse transcriptase to nucleic acid substrates.

Authors:  M Kruhøffer; C Urbanke; F Grosse
Journal:  Nucleic Acids Res       Date:  1993-08-25       Impact factor: 16.971

3.  Secondary structure of the HIV-2 leader RNA comprising the tRNA-primer binding site.

Authors:  B Berkhout; I Schoneveld
Journal:  Nucleic Acids Res       Date:  1993-03-11       Impact factor: 16.971

4.  Sulphydryl groups in the template-primer-binding domain of murine leukaemia virus reverse transcriptase. Identification and functional analysis of cysteine-90.

Authors:  S Basu; A Basu; M J Modak
Journal:  Biochem J       Date:  1993-12-15       Impact factor: 3.857

5.  RNA pseudoknots that inhibit human immunodeficiency virus type 1 reverse transcriptase.

Authors:  C Tuerk; S MacDougal; L Gold
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

6.  The 'helix clamp' in HIV-1 reverse transcriptase: a new nucleic acid binding motif common in nucleic acid polymerases.

Authors:  T Hermann; T Meier; M Götte; H Heumann
Journal:  Nucleic Acids Res       Date:  1994-11-11       Impact factor: 16.971

7.  Contributions of DNA polymerase subdomains to the RNase H activity of human immunodeficiency virus type 1 reverse transcriptase.

Authors:  J S Smith; K Gritsman; M J Roth
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

8.  Site-specific crosslinking of 4-thiouridine-modified human tRNA(3Lys) to reverse transcriptase from human immunodeficiency virus type I.

Authors:  Y Mishima; J A Steitz
Journal:  EMBO J       Date:  1995-06-01       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.